SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 307 filers reported holding SEATTLE GENETICS INC in Q4 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $92,286,000 | +13.9% | 471,592 | -1.1% | 0.07% | +5.9% |
| Q2 2020 | $81,000,000 | +50.7% | 476,692 | +2.4% | 0.07% | +19.3% |
| Q1 2020 | $53,732,000 | +26.2% | 465,692 | +25.0% | 0.06% | +29.5% |
| Q4 2019 | $42,572,000 | +33.7% | 372,592 | -0.1% | 0.04% | +29.4% |
| Q3 2019 | $31,845,000 | +25.6% | 372,892 | +1.8% | 0.03% | +25.9% |
| Q2 2019 | $25,359,000 | -7.2% | 366,400 | -1.8% | 0.03% | -10.0% |
| Q1 2019 | $27,326,000 | +33.6% | 373,100 | +3.4% | 0.03% | +15.4% |
| Q4 2018 | $20,454,000 | -25.0% | 361,000 | +2.1% | 0.03% | -13.3% |
| Q3 2018 | $27,270,000 | +12.6% | 353,600 | -3.1% | 0.03% | +7.1% |
| Q2 2018 | $24,219,000 | +32.5% | 364,800 | +4.5% | 0.03% | +27.3% |
| Q1 2018 | $18,272,000 | -7.0% | 349,100 | -4.9% | 0.02% | +4.8% |
| Q4 2017 | $19,645,000 | -1.7% | 367,200 | 0.0% | 0.02% | -8.7% |
| Q3 2017 | $19,979,000 | +6.1% | 367,200 | +0.9% | 0.02% | +4.5% |
| Q2 2017 | $18,823,000 | -14.7% | 363,800 | +3.6% | 0.02% | -18.5% |
| Q1 2017 | $22,064,000 | +51.7% | 351,000 | +27.4% | 0.03% | +17.4% |
| Q4 2016 | $14,543,000 | +58.0% | 275,600 | +61.7% | 0.02% | +53.3% |
| Q3 2016 | $9,203,000 | +28.0% | 170,400 | -4.2% | 0.02% | +25.0% |
| Q2 2016 | $7,189,000 | +13.6% | 177,900 | -4.7% | 0.01% | 0.0% |
| Q1 2016 | $6,327,000 | -2.3% | 186,700 | +29.4% | 0.01% | -25.0% |
| Q4 2015 | $6,476,000 | +16.4% | 144,300 | 0.0% | 0.02% | +14.3% |
| Q3 2015 | $5,564,000 | -1.7% | 144,300 | +23.4% | 0.01% | -6.7% |
| Q2 2015 | $5,658,000 | +37.4% | 116,900 | +0.3% | 0.02% | +36.4% |
| Q1 2015 | $4,118,000 | +11.4% | 116,500 | +1.3% | 0.01% | -21.4% |
| Q4 2014 | $3,695,000 | -11.4% | 115,000 | +2.5% | 0.01% | -12.5% |
| Q3 2014 | $4,172,000 | -4.6% | 112,200 | -1.8% | 0.02% | 0.0% |
| Q2 2014 | $4,372,000 | -16.1% | 114,300 | 0.0% | 0.02% | -20.0% |
| Q1 2014 | $5,208,000 | +47.7% | 114,300 | +29.3% | 0.02% | +42.9% |
| Q4 2013 | $3,526,000 | -8.5% | 88,400 | +0.6% | 0.01% | -12.5% |
| Q3 2013 | $3,853,000 | +33.3% | 87,900 | -4.4% | 0.02% | +23.1% |
| Q2 2013 | $2,891,000 | – | 91,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |